{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:10:51Z","timestamp":1790723451003,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Objective of the present study was to examine the association between adiponectin and hepatic steatosis, and other biochemical and anthropometric parameters in healthy subjects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 1349 subjects (age 18\u201365\u2009years) underwent ultrasound examination of the liver. Mean adiponectin concentration for the study collective was 11.35\u2009\u00b1\u20096.28\u2009\u03bcg\/mL. The following parameters were assessed for their association with adiponectin: body-mass index (BMI); age; sex; arterial blood pressure; nicotine use; alcohol consumption; physical activity; metabolic syndrome; total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol; triglycerides; aspartate aminotransferase (AST); alanine aminotransferase (ALT); \u03b3-glutamyltransferase (GGT); alkaline phosphatase (AP); C-reactive protein (CRP); insulin sensitivity according to the Homeostasis Model Assessment (HOMA); random blood glucose; and the degree of steatosis of the liver. The numerical differences in the variables influencing adiponectin returned in the descriptive analysis were confirmed at bivariate analysis for BMI, ALT, AST, GGT, AP, total and HDL cholesterol, triglycerides, CRP, arterial blood pressure, metabolic syndrome, nicotine use and alcohol consumption. The logistic regression of the multivariate analysis showed that male sex, hepatic steatosis, BMI, metabolic syndrome, tobacco smoking and CRP correlate negatively with adiponectin, while age, moderate alcohol consumption and HDL cholesterol exhibit a positive association.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The results of the present study confirm the findings of previous research. Adiponectin correlates negatively with cardiometabolic risk factors and is an independent indicator for non-alcoholic fatty liver disease (NAFLD).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-0500-7-207","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T01:01:46Z","timestamp":1396486906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample"],"prefix":"10.1186","volume":"7","author":[{"given":"Marion","family":"Flechtner-Mors","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel N","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suemeyra","family":"Oeztuerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M","family":"Haenle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard O","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"Graeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Kratzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atilla S","family":"Akinli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EMIL-Study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"2725_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1872-034X.2011.00824.x","volume":"41","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ: NASH a global health problem. Hepatol Res. 2011, 41: 670-674.","journal-title":"Hepatol Res"},{"key":"2725_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00428-011-1066-1","volume":"458","author":"A Tannapfel","year":"2011","unstructured":"Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, Flott-Rahmel B: Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch. 2011, 458: 511-523.","journal-title":"Virchows Arch"},{"key":"2725_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.dld.2009.01.004","volume":"41","author":"S Petta","year":"2009","unstructured":"Petta S, Muratore C, Craxi A: Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis. 2009, 41: 615-625.","journal-title":"Dig Liver Dis"},{"issue":"2 Suppl 1","key":"2725_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006, 43 (2 Suppl 1): 99-112.","journal-title":"Hepatology"},{"key":"2725_CR5","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley BQ, Calcagno CJ, Harrison SA: Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010, 51: 1820-1832.","journal-title":"Hepatology"},{"key":"2725_CR6","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/hep.26183","volume":"57","author":"SK Park","year":"2013","unstructured":"Park SK, Seo MH, Shin HC, Ryoo JH: The clinical availability of non-alcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5-years\u2019 prospective cohort study. Hepatology. 2013, 57: 1378-1383.","journal-title":"Hepatology"},{"key":"2725_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4250\/jcu.2012.20.3.124","volume":"20","author":"SP Lee","year":"2012","unstructured":"Lee SP: Non-alcoholic fatty liver disease, a marker of subclinical atherosclerosis applicable only to metabolic syndrome?: Time to organize the connection between metabolism and atherosclerosis. J Cardiovasc Ultrasound. 2012, 20: 124-125.","journal-title":"J Cardiovasc Ultrasound"},{"key":"2725_CR8","first-page":"2801","volume":"17","author":"C Buechler","year":"2011","unstructured":"Buechler C, Wanninger J, Neumeier M: Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol. 2011, 17: 2801-2811.","journal-title":"World J Gastroenterol"},{"key":"2725_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003, 37: 917-923.","journal-title":"Hepatology"},{"key":"2725_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/JCI34275","volume":"118","author":"C Postic","year":"2008","unstructured":"Postic C, Girard J: Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engeneered mice. J Clin Invest. 2008, 118: 829-838.","journal-title":"J Clin Invest"},{"key":"2725_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000318741","volume":"83","author":"A Wree","year":"2011","unstructured":"Wree A, Kahraman A, Gerken G, Canbay A: Obesity affects the liver - the link between adipocytes and hepatocytes. Digestion. 2011, 83: 124-133.","journal-title":"Digestion"},{"key":"2725_CR12","first-page":"1532","volume":"16","author":"M Sanjari","year":"2011","unstructured":"Sanjari M, Khodashahi M, Gholamhoseinian A, Shokooki M: Association of adiponectin and metabolic syndrome in women. J Res Med Sci. 2011, 16: 1532-40.","journal-title":"J Res Med Sci"},{"key":"2725_CR13","first-page":"271","volume":"132","author":"K Gokulakrishnan","year":"2010","unstructured":"Gokulakrishnan K, Anjana RM, Indulekha K, Anuradha S, Mohan V: Association of hypoadiponectinemia with non-alcoholic fatty liver disease in urban south Indians\u2013(CURES - 81). Indian J Med Res. 2010, 132: 271-277.","journal-title":"Indian J Med Res"},{"key":"2725_CR14","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3748\/wjg.v11.i12.1737","volume":"11","author":"N Mendez-Sanchez","year":"2005","unstructured":"Mendez-Sanchez N, Chavez-Tapia NC, Villa AR, Sanchez-Lara K, Zamona-Valdes D, Ramos MH, Uribe M: Adiponectin as a protective factor in hepatic steatosis. World J Gastroenterol. 2005, 11: 1737-1741.","journal-title":"World J Gastroenterol"},{"key":"2725_CR15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.metabol.2011.03.009","volume":"60","author":"P Pisto","year":"2011","unstructured":"Pisto P, Ukkola O, Santaniemi M, Kes\u00e4niemi YA: Plasma adiponectin - an independent indicator of liver fat accumulation. Metabolism. 2011, 60: 1515-1520.","journal-title":"Metabolism"},{"key":"2725_CR16","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1210\/jc.2004-2240","volume":"90","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G: Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. 2005, 90: 3498-3504.","journal-title":"J Clin Endocrinol Metab"},{"key":"2725_CR17","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1210\/jc.2004-0303","volume":"89","author":"A B\u00f6ttner","year":"2004","unstructured":"B\u00f6ttner A, Kratsch J, M\u00fcller G, Kapellen TM, Bl\u00fcher S, Keller E, Bl\u00fcher M, Kiess W: Gender differences of adiponectin levels develop during the progression of puberty and are relared to serum androgen levels. J Clin Endocrinol Metab. 2004, 89: 4053-4062.","journal-title":"J Clin Endocrinol Metab"},{"key":"2725_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1055\/s-0028-1083780","volume":"40","author":"S Horenburg","year":"2008","unstructured":"Horenburg S, Fischer-Posovszky P, Debatin KM, Wabitsch M: Influence of sex hormones on adiponectin expression in human adipocytes. Horm Metab Res. 2008, 40: 779-786.","journal-title":"Horm Metab Res"},{"key":"2725_CR19","first-page":"713","volume":"16","author":"G Mohammadzadeh","year":"2011","unstructured":"Mohammadzadeh G, Zarghami N: Hypoadiponectinemia in obese subjects with type II diabetes: A close association with central obesity indices. J Res Med Sci. 2011, 16: 713-723.","journal-title":"J Res Med Sci"},{"key":"2725_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5551\/jat.7625","volume":"18","author":"K Kishida","year":"2011","unstructured":"Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I: Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb. 2011, 18: 592-595.","journal-title":"J Atheroscler Thromb"},{"key":"2725_CR21","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1210\/jc.2006-2614","volume":"92","author":"AJ Hanley","year":"2007","unstructured":"Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM: Association of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab. 2007, 92: 2665-2671.","journal-title":"J Clin Endocrinol Metab"},{"key":"2725_CR22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/00365513.2011.554995","volume":"71","author":"PP Mujumdar","year":"2011","unstructured":"Mujumdar PP, Duerksen-Hughes PJ, Firek AF, Hessinger DA: Long-term, progressive, aerobic training increases adiponectin in middle-aged, overweight, untrained males and females. Scand J Clin Lab Invest. 2011, 71: 101-107.","journal-title":"Scand J Clin Lab Invest"},{"key":"2725_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1249\/MSS.0b013e318228bf85","volume":"44","author":"KR Kelly","year":"2012","unstructured":"Kelly KR, Blaszczak A, Haus JM, Patrick-Melin A, Fealy CE, Solomon TP, Kalinski MI, Kirwan JP: A 7-d exercise program increases high-molecular weight adiponectin in obese adults. Med Sci Sports Exerc. 2012, 44: 69-74.","journal-title":"Med Sci Sports Exerc"},{"key":"2725_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","volume":"56","author":"C Thoma","year":"2012","unstructured":"Thoma C, Day CP, Trenell MI: Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012, 56: 255-266.","journal-title":"J Hepatol"},{"key":"2725_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11906-008-0035-9","volume":"10","author":"MJ Brookes","year":"2008","unstructured":"Brookes MJ, Igbal TH, Cooper BT: Hypertension and hepatic steatosis. Curr Hypetens Rep. 2008, 10: 182-187.","journal-title":"Curr Hypetens Rep"},{"key":"2725_CR26","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/HJH.0b013e32833c211b","volume":"28","author":"K Lau","year":"2010","unstructured":"Lau K, Lorbeer R, Haring R, Schmidt CO, Wallaschofski H, Nauck M, John U, Baumeister SE, V\u00f6lzke H: The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study. J Hypertens. 2010, 28: 1829-1835.","journal-title":"J Hypertens"},{"key":"2725_CR27","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","volume":"23","author":"A Lopez-Suarez","year":"2011","unstructured":"Lopez-Suarez A, Guerrero JM, Elvirs-Gonzalez J, Beltran-Robles M, Canas-Hormigo F, Bascunana-Quirell A: Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. Eur J Gastrenterol Hepatol. 2011, 23: 1011-1017.","journal-title":"Eur J Gastrenterol Hepatol"},{"key":"2725_CR28","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1373\/clinchem.2006.067397","volume":"52","author":"K Kantartzis","year":"2006","unstructured":"Kantartzis K, Rittig K, Balletshofer B, Machann J, Schick F, Porubska K, Fritsche A, H\u00e4ring HU, Stefan N: The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem. 2006, 52: 1934-1942.","journal-title":"Clin Chem"},{"key":"2725_CR29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi T, Kamon J, Ito Y, Suchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003, 423: 762-769.","journal-title":"Nature"},{"key":"2725_CR30","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/01.ATV.0000219611.50066.bd","volume":"26","author":"B Verges","year":"2006","unstructured":"Verges B, Petit JM, Duvillard L, Dautin G, Florentin E, Galland F, Gambert P: Adiponectin is an important determinant of apoA-I catabolism. Arterioscler Thromb Vasc Biol. 2006, 26: 1364-1369.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2725_CR31","first-page":"35","volume":"17","author":"SX Lin","year":"2007","unstructured":"Lin SX, Pi-Sunyer EX: Prevalence of the metabolic syndrome among US middle-aged and older adults with and without diabetes - a prliminary analysis of the NHANES 1999\u20132002 data. Ethn Dis. 2007, 17: 35-39.","journal-title":"Ethn Dis"},{"key":"2725_CR32","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.biochi.2012.06.008","volume":"94","author":"K Ohashi","year":"2012","unstructured":"Ohashi K, Ouchi N, Matszawa Y: Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012, 94: 2137-2142.","journal-title":"Biochimie"},{"key":"2725_CR33","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.2174\/092986712803833254","volume":"19","author":"AR Moschen","year":"2012","unstructured":"Moschen AR, Wieser V, Tilg H: Adiponectin: key player in the adipose tissue-liver crosstalk. Curr Med Chem. 2012, 19: 5467-","journal-title":"Curr Med Chem"},{"key":"2725_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"A Xu","year":"2003","unstructured":"Xu A, Wang Y, Keshaw H, Xu L, Lam KS, Cooper GJ: The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver disease in mice. J Clin Invest. 2003, 112: 91-100.","journal-title":"J Clin Invest"},{"key":"2725_CR35","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2337\/dc12-0223","volume":"36","author":"JY Kim","year":"2012","unstructured":"Kim JY, Ahn SV, Yoon JH, Koh SB, Yoon J, Yoo BS, Lee SH, Park JK, Choe KH, Guallar E: Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG Study. Diabetes Care. 2012, 36: 1547-1553.","journal-title":"Diabetes Care"},{"key":"2725_CR36","first-page":"234","volume":"217","author":"M Juonala","year":"2011","unstructured":"Juonala M, Saarikoski LA, Vikari JS, Oikonen M, Lehtim\u00e4ki T, Lyytik\u00e4inen LP, Huupponen R, Magnussen CG, Koskinen J, Laitinen T, Taittonen L, K\u00e4h\u00f6nen M, Kivim\u00e4ki M, Raitakari OT: A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardivascular Risk in Young Finns Study. Atherosclerosis. 2011, 217: 234-239.","journal-title":"The Cardivascular Risk in Young Finns Study. Atherosclerosis"},{"key":"2725_CR37","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00125-008-1031-y","volume":"51","author":"MM Joosten","year":"2008","unstructured":"Joosten MM, Beulens JW, Kersten S, Hendriks HF: Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia. 2008, 51: 1375-1381.","journal-title":"Diabetologia"},{"key":"2725_CR38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2337\/dc08-1723","volume":"32","author":"A Imhof","year":"2009","unstructured":"Imhof A, Plamper I, Maier S, Rischler G, Koenig W: Effect of drinking on adiponectin in healthy men and women: a randomized intervention study of water, ethanol, red wine, and beer with or without alcohol. Diabetes Care. 2009, 32: 1101-1103.","journal-title":"Diabetes Care"},{"key":"2725_CR39","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1210\/jc.2009-1862","volume":"95","author":"Y Nishise","year":"2010","unstructured":"Nishise Y, Saito T, Makino N, Okumoto K, Ito JI, Watanabe H, Saito K, Togashi H, Ikeda C, Kubota I, Daimon M, Kato T, Fukao A, Kawata S: Relationship between alcohol consumption and serum adiponectin levels: the Takahata study - a cross-sectional study of a healthy Japanese population. J Clin Endocrinol Metab. 2010, 95: 3828-3835.","journal-title":"J Clin Endocrinol Metab"},{"key":"2725_CR40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/01.HYP.0000169444.05588.4c","volume":"45","author":"Y Iwashima","year":"2005","unstructured":"Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, Ouchi N, Ohashi K, Kihara S, Funahashi T, Rakugi H, Ogihara T: Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005, 45: 1094-1100.","journal-title":"Hypertension"},{"key":"2725_CR41","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1515\/cclm-2011-0852","volume":"50","author":"JS Tsai","year":"2012","unstructured":"Tsai JS, Guo FR, Chen SC, Lue BH, Lee LT, Huang KC, Chen CY, Hung SH, Chuang LM, Chen CY: Changes of serum adiponectin and soluable intercellular adhesion molecule-1 concentrations after smoking cessation. Clin Chem Lab Med. 2012, 50: 1063-1069.","journal-title":"Clin Chem Lab Med"},{"key":"2725_CR42","doi-asserted-by":"publisher","first-page":"e9527","DOI":"10.5812\/hepatmon.9527","volume":"13","author":"M Hashemi","year":"2013","unstructured":"Hashemi M, Hanafi Bojd H, Eskandari Nasab E, Bahari A, Hashemzehi NA, Shafieipour S, Narouie B, Taheri M, Ghavami S: Association of adiponectin rs266729 gene polymorphism with nonalcoholic fatty liver disease. Hepat Mon. 2013, 13: e9527-","journal-title":"Hepat Mon"},{"key":"2725_CR43","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3945\/ajcn.113.063792","volume":"98","author":"G Musso","year":"2013","unstructured":"Musso G, Bo S, Cassader M, De Michieli F, Gambino R: Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on severity of liver disease and of glucose and lipid dysmetabolism. Am J Clin Nutr. 2013, 98: 895-906.","journal-title":"Am J Clin Nutr"},{"key":"2725_CR44","doi-asserted-by":"publisher","first-page":"e50256","DOI":"10.1371\/journal.pone.0050256","volume":"7","author":"XE Peng","year":"2012","unstructured":"Peng XE, Wu YL, Lin SW, Lu QQ, Hu ZJ, Lin X: Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease. Plos One. 2012, 7: e50256-","journal-title":"Plos One"},{"key":"2725_CR45","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jpeds.2010.11.016","volume":"158","author":"YC Lin","year":"2011","unstructured":"Lin YC, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH: A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr. 2011, 158: 740-744.","journal-title":"J Pediatr"},{"key":"2725_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-230X-12-111","volume":"12","author":"L Valenti","year":"2012","unstructured":"Valenti L, Rametta R, Ruscica M, Dongiovanni P, Steffani L, Motta BM, Canavesi E, Fracanzani AL, Mozzi E, Roviaro G, Magni P, Fargion S: The l148 PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol. 2012, 12: 111-","journal-title":"BMC Gastroenterol"},{"key":"2725_CR47","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.2174\/13816128113199990360","volume":"19","author":"I Padmalayam","year":"2013","unstructured":"Padmalayam I, Suto M: Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy. Curr Pharm Des. 2013, 19: 5755-5763.","journal-title":"Curr Pharm Des"},{"key":"2725_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1463-1326.2005.00510.x","volume":"8","author":"JP Whitehead","year":"2006","unstructured":"Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB: Adiponectin\u2013a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006, 8: 264-280.","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 7","key":"2725_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ijo.2008.233","volume":"32","author":"T Yamauchi","year":"2008","unstructured":"Yamauchi T, Kadowaki T: Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes. 2008, 32 (Suppl 7): 13-18.","journal-title":"Int J Obes"},{"key":"2725_CR50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/HJH.0b013e328013cd67","volume":"25","author":"F Lanni","year":"2007","unstructured":"Lanni F, Santulli G, Izzo R, Rubattu S, Zanda B, Volpe M, Iaccarino G, Trimarco B: The PI(A1\/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: Increased risk of ischemic stroke in high-risk patients. J Hypertens. 2007, 25: 551-556.","journal-title":"J Hypertens"},{"key":"2725_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2261-10-41","volume":"10","author":"G Galasso","year":"2010","unstructured":"Galasso G, Santulli G, Piscione F, De Rosa R, Trimarco V, Piccolo R, Cassese S, Iaccarino G, Trimarco B, Chiariello M: The GPIIIa PIA2 polymorphism is associated with an increased risk of cardiovascular adverse events. BMC Cardiovasc Disord. 2010, 10: 41-","journal-title":"BMC Cardiovasc Disord"},{"key":"2725_CR52","doi-asserted-by":"publisher","first-page":"e001081","DOI":"10.1161\/JAHA.112.001081","volume":"1","author":"G Santulli","year":"2012","unstructured":"Santulli G, Cipoletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G: CaMK4 gene deletion induces hypertension. J Am Heart Assoc. 2012, 1: e001081-","journal-title":"J Am Heart Assoc"},{"key":"2725_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/1471-2458-6-233","volume":"6","author":"MM Haenle","year":"2006","unstructured":"Haenle MM, Brockmann SO, Kron M, Bertling U, Mason RA, Steinbach G, Boehm BO, Koenig W, Kern P, Piechotowski I, Kratzer W, EMIL-Study group: Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health. 2006, 6: 233-","journal-title":"BMC Public Health"},{"key":"2725_CR54","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645.","journal-title":"Circulation"},{"key":"2725_CR55","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1053\/gast.2002.36572","volume":"123","author":"AJ Sanyal","year":"2002","unstructured":"Sanyal AJ: AGA technical review on nonalcoholic fatty liver disease. Gastroenterolgy. 2002, 123: 1705-1725.","journal-title":"Gastroenterolgy"},{"key":"2725_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-0028-1109894","volume":"31","author":"W Kratzer","year":"2010","unstructured":"Kratzer W, Akinli AS, Bommer M, Arnold F, Eggink S, Imhof A, Mason RA, Klaus J, Schuler A, Boehm BO, Haenle MM: Prevalence and risk factors of focal sparing in hepatic steatosis. Ultraschall Med. 2010, 31: 37-42.","journal-title":"Ultraschall Med"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:18:37Z","timestamp":1630552717000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2725"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-207","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]},"assertion":[{"value":"30 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"207"}}